Evidence map›Paper›PMID 39937237›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.

Melissa R Perrino, Marjolijn C J Jongmans, Gail E Tomlinson, Mary-Louise C Greer, Sarah R Scollon, Sarah G Mitchell, Jordan R Hansford, Kris Ann P Schultz, Wendy K Kohlmann, Jennifer M Kalish and 13 more

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Hybrid schwannoma-neurofibroma of the upper cervical spine: illustrative case and systematic review of spinal hybrid nerve sheath tumors.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Melissa R PerrinoDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-0598-7102
Marjolijn C J JongmansPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0001-6572-4374
Gail E TomlinsonDivision of Hematology-Oncology, Department of Pediatrics, UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas.ORCID 0000-0003-2579-1833
Mary-Louise C GreerDepartment of Diagnostic and Interventional Radiology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.ORCID 0000-0001-6159-5472
Sarah R ScollonDivision of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-2017-0245
Sarah G MitchellDepartment of Pediatric Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.ORCID 0000-0003-1656-2799
Jordan R HansfordMichael Rice Centre for Hematology and Oncology, South Australia Health and Medical Research Institute, South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, Australia.ORCID 0000-0001-7733-383X
Kris Ann P SchultzCancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1788-5832
Wendy K KohlmannVA National TeleOncology Program, Durham, North Carolina.ORCID 0000-0002-9134-9640
Jennifer M KalishDivision of Human Genetics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0003-1500-9713
Suzanne P MacFarlandDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-5894-6403
Anirban DasDivision of Paediatric Haematology and Oncology, Hospital for Sick Children, University of Toronto, Toronto, Canada.ORCID 0000-0001-7653-9529
Kara N MaxwellDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-8192-4202
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Division Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg University Hospital and National Center for Tumor Diseases (NCT), Heidelberg, Germany.ORCID 0000-0002-5447-5322
Rosanna WeksbergDivision of Clinical and Metabolic Genetics, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, Canada.ORCID 0000-0002-6501-4150
Orli MichaeliDivision of Hematology/Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.ORCID 0000-0002-6097-6457
Uri TaboriDivision of Paediatric Haematology and Oncology, Hospital for Sick Children, University of Toronto, Toronto, Canada.ORCID 0000-0002-5019-2683
Gina M NeyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.ORCID 0000-0002-6530-780X
Philip J LupoDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-0978-5863
Jack J BrzezinskiDivision of Paediatric Haematology and Oncology, Hospital for Sick Children, University of Toronto, Toronto, Canada.ORCID 0000-0002-9475-0077
Douglas R StewartDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.ORCID 0000-0001-8193-1488
Emma R WoodwardManchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.ORCID 0000-0002-6297-2855
Christian P KratzPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4120-5873

Funding

Genetic Modifiers of Cancer RiskZIACP010142 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MIRABELLO, LISA · 2009 to 2025
$17.1M
American Lebanese Syrian Associated Charities (ALSAC)Deutsche Kinderkrebsstiftung (German Childhood Cancer Foundation) DKS2024.03Hospital Research Foundation (HRF)Intramural NIH HHS ZIA CP010142Manchester Biomedical Research Centre (BRC) NIHR203308McClurg FoundationNational Cancer Institute (NCI)
6 · The paper itself

Abstract

Schwannomatosis (SWN) is a distinct cancer predisposition syndrome caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is a significant clinical overlap between these syndromes with the hallmark of increased risk for cranial, spinal, and peripheral schwannomas. Neurofibromatosis type 2 was recently renamed as NF2-related SWN and is the most common SWN syndrome, with increased risk for bilateral vestibular schwannomas, intradermal schwannomas, meningiomas, and less commonly, ependymoma. SMARCB1-related SWN is a familial SWN syndrome associated with peripheral and spinal schwannomas and an increased risk for meningiomas and malignant peripheral nerve sheath tumors, even in the absence of radiation. These individuals do not develop bilateral vestibular schwannomas. Finally, patients with LZTR1-related SWN typically present with peripheral schwannomas, and unilateral vestibular schwannomas have been reported. The following perspective is intended to highlight the clinical presentation and international tumor surveillance recommendations across these SWN syndromes.

Indexed as

Central Nervous System NeoplasmsNeurilemmomaNeurofibromatosesNeurofibromatosis 2Neurofibromin 2Skin NeoplasmsSMARCB1 ProteinTranscription FactorsChildGenetic Predisposition to DiseaseHumansLZTR1 protein, humanNeurofibromin 2NF2 protein, humanSMARCB1 ProteinSMARCB1 protein, humanTranscription Factors

Identifiers

PMID39937237
PMCPMC12002630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.